Contact an Infusion pump lawyer
July 22nd, 2005
"Baxter halts shipments of Colleague brand infusion pumps"
Baxter International Inc. announced yesterday it has halted shipments of a popular infusion pump because of dangerous design problems. The company said about 250,000 of its Colleague brand pump used to administer intravenous medicines to patients might have a product flaw responsible for three deaths and six serious injuries.
Baxter said it plans on fixing the medical products, but the infusion pump recall forced the company to take a $65 million charge for the second quarter. A design flaw was first reported to customers in March that could disrupt infusions of intravenous therapies to patients. The decision to withhold further shipments was made after Baxter said it discovered a separate problem with certain models of the pump.
The FDA classified the Baxter Colleague recall as a “Class I,” or the most serious type of recall issued. Baxter must fix the estimated 250,000 devices already in use, but the company said only a small number of the devices have been affected by the safety flaws.